SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Agouron Pharmaceuticals (AGPH)
An SI Board Since March 1996
Posts SubjectMarks Bans Symbol
6136 24 0 AGPH
Emcee:  Bhag Karamchandani Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
4661 Henry: further regarding salvage from protease inhibitor resistance: healthcg.cJoe E.-6/30/1998
4660 Experimental AIDS Drugs Work Faster, Better, Companies Say In Geneva Steve Fancy-6/30/1998
4659 margie <<The Sustiva data is "Intent to treat" data, where theJoe E.-6/30/1998
4658 All's post is worth reading a second time. Very good analysis. I found the margie-6/30/1998
4657 Richard, I feel privileged to be a don't-have-a-biological-clue individual!Intel Trader-6/30/1998
4656 You're right Richard. Just a friend of the family with AIDS and a good Steve Fancy-6/30/1998
4655 Folks, worth reading a second time ... from Rick's post immediately precePeter Singleton-6/30/1998
4654 "I realize now, more than ever, that we have several individuals that are sam-6/30/1998
4653 I realize now, more than ever, that we have several individuals that are devotescaram(o)uche-6/30/1998
4652 Sam, we really want to get this thing up above and away from the 30 level. Steve Fancy-6/30/1998
4651 I believe they did issue a press release about phase II/III -- a day or so aftesam-6/30/1998
4650 Glad you called IR; very helpful info. I'm just wondering about the monies Izzy-6/30/1998
4649 best I can find, not much...... Tanpakushitsu Kakusan Koso 1998 May;43(6):744-scaram(o)uche-6/30/1998
4648 I think that Agouron wants to make sure that they are an important player in thAndreas Helke-6/30/1998
4647 Just off the horn with AGPH IR. a. They are comfortable with earnings going Intel Trader-6/30/1998
4646 Sustiva Analysis While Sustiva will play an important role in HIV therapies, aALL-6/30/1998
4645 Henry: I don't think this has been studied extensively with patients, but IJoe E.-6/30/1998
4644 Izzy, I think initially its being perceived as AGPH hot air. I have no opinSteve Fancy-6/30/1998
4643 Bhag: >> if honest concerns are raised - even if based on ignorance, andscaram(o)uche-6/30/1998
4642 What do you all think about AGPH acquiring rights to develop a "novel HIVIzzy-6/30/1998
4641 I hope you're right Intel, but days like today offer a convincing arguemSteve Fancy-6/30/1998
4640 6/30/98 WSJ link on Sustiva interactive.wsj.comALL-6/30/1998
4639 Rick: Aren't you glad you're not a clinical physician? Decisions...deciIzzy-6/30/1998
4638 Steve, you may be right, but here are a few things to keep in mind: a. AgouronIntel Trader-6/30/1998
4637 In general, Biotech companies may be starting to behave like technology companiBhag Karamchandani-6/30/1998
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News